Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

Genetic disorder involving ion channels of the cellular membrane and affecting electrolyte conductance leading to episodic muscle weakness. It is characterized by episodes of flaccid muscle weakness occuring at irregular intervals. Most of the conditions are hereditary.

Familial Periodic Paralysis, Hypokalemia, Hyperkalemia, Myotonia, Paramyotonia Congenita, Potassium-aggravated Myotonia; Becker Myotonia Congenita; Thomsen Myotonia Congenita; Adynamia Episodica Hereditaria with or without Myotonia; Gamstorp Disease; Thyrotoxic Periodic Paralysis.

Primary periodic paralysis can be classified according to the membrane electrolyte defect:

Sodium Channel: Hyperkalemic PP; Paramyotonia Congenita; Potassium-aggravated myotonia

Calcium Channel: Hypokalemic PP; Thyrotoxic PP (secondary form)

Chloride Channel: Normokalemic PP; Becker Myotonia Congenita; Thomsen Myotonia Congenita

In the United States, the frequency for all forms of PP remains unknown. Hypokalemic periodic paralysis form is the most common. It has a prevalence of 1 per 100,000 population. Becker myotonia congenita has a reported prevalence of 1 per 50,000, whereas Thomsen myotonia congenita seems significantly rarer. Internationally, the incidence for this medical condition has not been established. Thyrotoxic periodic paralysis is more common in males (85%) of Asian descent, leading to a frequency of approximately 2%.

All are autosomal dominant but penetrance seems to be variable in female carriers. Hypokalemic periodic paralysis is caused by a mutation in the alpha-1 unit of the dihydropyridine-sensitive calcium channel CACNL1A3; the gene is located on chromosome 1q31-32. Hyperkalemic periodic paralysis is caused by a mutation in the alpha subunit of the Na channel SCN4A; the gene is located on chromosome 17q13.1-q13.3. It is the same gene as paramyotonia congenita. The gene of normokalemic periodic paralysis is still unknown—whether it is a separate entity or a subgroup of the hyperkalemic form is a subject of debate.

The physiopathologic basis of flaccid muscle weakness is inexcitability of the muscle membrane, i.e., the sarcolemma. In the hypokalemic form, potassium (K) outflow is diminished by altered calcium homeostasis in the muscle fibers; in the hyperkalemic form, the muscle fibers remain depolarized and their membranes are inexcitable.

Based on history, clinical examination, and measurement of serum electrolytes during the attacks.

Hypokalemic form: Onset rarely occurs before the second decade of life. Attacks of muscle weakness typically occur at night or in the early morning. They are triggered by increased physical exercise, stress, cold, or a large carbohydrate intake. Paralysis is flaccid, affects mainly the girdle of the lower limbs, and spares the respiratory muscles as well as the muscles supplied by the cranial nerves. The attack usually lasts 6 to 24 hours. ECG signs of hypokalemia can be observed. Treatment: Oral KCl in case of attack but electrolytes should be monitored as rebound hyperkalemia is frequent; prophylaxis with acetazolamide or spironolactone. Thyrotoxic periodic paralysis is the most common hypokalemic PP. It is most common in adults 20-40 years of age. Hyperinsulinemia, carbohydrate load, and exercise may all cause PP ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.